NeoGenomics, Inc.

NEO ·Healthcare, Diagnostics & Research, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2018

Total Assets: $505.0M

Liabilities Breakdown FY2018

Total Liabilities: $184.6M